Publikationer

• Issa II, Due H, Brøndum RF, Veeravakaran V, Haraldsdóttir H, Sylvester C, Brogaard A, Dhanjal S, Schmierer B, Dybkær K. CRISPR-Cas9 Knockout Screens Identify DNA Damage Response Pathways and BTK as Essential for Cisplatin Response in Diffuse Large B-Cell Lymphoma. Cancers (Basel). 2024 Jul 2;16(13):2437. doi: 10.3390/cancers16132437. PMID: 39001501
  
  
• Bentestuen M, Ladekarl M, Knudsen A, Zacho HD. Diagnostic accuracy and clinical value of [68Ga]Ga-FAPI-46 PET/CT for staging patients with ovarian cancer: study protocol for a prospective clinical trial. BMC Cancer. 2024 Jun 7;24(1):699. doi: 10.1186/s12885-024-12461-w. PMID: 38849741
  
  
• Terp SK, Pedersen IS, Stoico MP. Extraction of Cell-Free DNA: Evaluation of Efficiency, Quantity, and Quality. J Mol Diagn. 2024 Apr;26(4):310-319. doi: 10.1016/j.jmoldx.2024.01.008. Epub 2024 Feb 2. PMID: 38336350
  
  
• Mark LR, Terp SK, Krarup HB, Thomassen M, Pedersen IS, Bøgsted M. Homologous Recombination Deficiency Detection Algorithms: A Systematic Review. Cancers. 2023 nov. 29;15(23):5633. PMID:38067337
  
  
• Ladekarl, M., Nøhr, A. K., Sønderkær, M., Dahl, S. C., Sunde, L., Vestereghem, C., Mapendano, C. K., Haslund, C. A., Pagh, A., Carus, A., Lörincz, T., Nowicka-Matus, K., Poulsen, L. Ø., Laursen, R. J., Dybkær, K., Poulsen, B. K., Frøkjær, J. B., Brügmann, A. H., Ernst, A., Wanders, A., … Pedersen, I. S. (2023). Feasibility and early clinical impact of precision medicine for late-stage cancer patients in a regional public academic hospital. Acta oncologica (Stockholm, Sweden), 62(3), 261–271. PMID:36905645
  
  
• Terp, S. K., Stoico, M. P., Dybkær, K., & Pedersen, I. S. (2023). Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review. Clinical epigenetics, 15(1), 24. PMID:36788585
  
  
• Kringelbach, T., Højgaard, M., Rohrberg, K., Spanggaard, I., Laursen, B. E., Ladekarl, M., Haslund, C. A., Harsløf, L., Belcaid, L., Gehl, J., Søndergaard, L., Eefsen, R. L., Hansen, K. H., Kodahl, A. R., Jensen, L. H., Holt, M. I., Oellegaard, T. H., Yde, C. W., Ahlborn, L. B., & Lassen, U. (2023). ProTarget: a Danish Nationwide Clinical Trial on Targeted Cancer Treatment based on genomic profiling - a national, phase 2, prospective, multi-drug, non-randomized, open-label basket trial. BMC cancer, 23(1), 182. PMID:36814246
  
  
• Schmidt, L., Issa, I. I., Haraldsdóttir, H., Hald, J. L., Schmitz, A., Due, H., & Dybkær, K. (2022). Hsp90 inhibition sensitizes DLBCL cells to cisplatin. Cancer chemotherapy and pharmacology, 89(4), 431–440. PMID:35190872

• Mapendano CK, Nøhr AK, Sønderkær M, Pagh A, Carus A, Lörincz T, Haslund CA, Poulsen LØ, Ernst A, Bødker JS, Dahl SC, Sunde L, Brügmann AH, Vesteghem C, Pedersen IS, Ladekarl M. Longer survival with precision medicine in late-stage cancer patients. ESMO Open. 2025 Jan 3;10(1):104089. doi: 10.1016/j.esmoop.2024.104089. Epub ahead of print. PMID:39754975

• Egendal I, Rasmus Froberg Brøndum, Pelizzola M, Asger Hobolth, Bøgsted M. On the Relation Between Linear Autoencoders and Non-Negative Matrix Factorization for Mutational Signature Extraction. Journal of Computational Biology. 2025 Mar 21 PMID:40113251

‌